The fine line between familial and polygenic hypercholesterolemia

Author： De Castro-Orós Isabel   Pocoví Miguel   Civeira Fernando  

Publisher： Future Medicine

ISSN： 1758-4299

Source： Clinical Lipidology, Vol.8, Iss.3, 2013-06, pp. : 303-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homozygous familial hypercholesterolemia

By Wierzbicki Anthony S  

Clinical Lipidology, Vol. 8, Iss. 4, 2013-08 ,pp. : 407-409

Future Medicine

Access to resources Recommend Favorite

Lipoprotein apheresis for the treatment of familial hypercholesterolemia

By Walji Shahenaz   Neuwirth Clare   Thompson Gilbert R  

Clinical Lipidology, Vol. 8, Iss. 5, 2013-10 ,pp. : 573-586

Future Medicine

Access to resources Recommend Favorite

Complex genetics of monogenic familial hypercholesterolemia

By Koeijvoets Kristel CMC   van der Net Jeroen B   Dallinga-Thie Geesje M   Steyerberg Ewout W   Sijbrands Eric JG  

Future Lipidology, Vol. 1, Iss. 5, 2006-10 ,pp. : 527-538

Future Medicine

Access to resources Recommend Favorite

Soluble P-Selectin and Proinflammatory Cytokines in Patients with Polygenic Type IIa Hypercholesterolemia

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 5, 2000-04 ,pp. : 277-285

Karger

Access to resources Recommend Favorite

Current challenges in the management of patients with familial hypercholesterolemia

By Arca Marcello   Salvia Elena   Pigna Giovanni  

Clinical Lipidology, Vol. 8, Iss. 2, 2013-04 ,pp. : 217-229

Future Medicine

Access to resources Recommend Favorite